Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1534-4681

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping ; day:21 ; month:10 ; year:2016 ; pages:1-7
Annals of surgical oncology ; (21.10.2016), 1-7

Creator: Whitworth, Pat

Contributor: Beitsch, Peter
Mislowsky, Angela
Pellicane, James V.
Nash, Charles
Murray, Mary
Lee, Laura A.
Dul, Carrie L.
Rotkis, Michael
Baron, Paul
Stork-Sloots, Lisette
Snoo, Femke A. de
Beatty, Jennifer
SpringerLink (Online service)

DOI: 10.1245/s10434-016-5600-x

URN: urn:nbn:de:1111-201611204108

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Whitworth, Pat
Beitsch, Peter
Mislowsky, Angela
Pellicane, James V.
Nash, Charles
Murray, Mary
Lee, Laura A.
Dul, Carrie L.
Rotkis, Michael
Baron, Paul
Stork-Sloots, Lisette
Snoo, Femke A. de
Beatty, Jennifer
SpringerLink (Online service)

Other Objects (12)

Breast cancer subtyping from plasma proteins

Molecular subtyping for clinically defined breast cancer subgroups

CDK4/6 inhibition in luminal breast cancer

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Triple-negative breast cancer molecular subtyping and treatment progress

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

GRHL2-controlled gene expression networks in luminal breast cancer

Chemosensitivity testing in gynecologic malignancies and breast cancer : 30 tables

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells

Breast cancer subtyping from plasma proteins

Molecular subtyping for clinically defined breast cancer subgroups

CDK4/6 inhibition in luminal breast cancer

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Triple-negative breast cancer molecular subtyping and treatment progress

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

GRHL2-controlled gene expression networks in luminal breast cancer

Chemosensitivity testing in gynecologic malignancies and breast cancer : 30 tables

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells

Breast cancer subtyping from plasma proteins

Molecular subtyping for clinically defined breast cancer subgroups

CDK4/6 inhibition in luminal breast cancer

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Triple-negative breast cancer molecular subtyping and treatment progress

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

GRHL2-controlled gene expression networks in luminal breast cancer

Chemosensitivity testing in gynecologic malignancies and breast cancer : 30 tables

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Breast cancer subtyping from plasma proteins

Molecular subtyping for clinically defined breast cancer subgroups

CDK4/6 inhibition in luminal breast cancer

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Triple-negative breast cancer molecular subtyping and treatment progress

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

GRHL2-controlled gene expression networks in luminal breast cancer

Chemosensitivity testing in gynecologic malignancies and breast cancer : 30 tables

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells

Breast cancer subtyping from plasma proteins

Molecular subtyping for clinically defined breast cancer subgroups

CDK4/6 inhibition in luminal breast cancer

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Triple-negative breast cancer molecular subtyping and treatment progress

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

GRHL2-controlled gene expression networks in luminal breast cancer

Chemosensitivity testing in gynecologic malignancies and breast cancer : 30 tables

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells

Breast cancer subtyping from plasma proteins

Molecular subtyping for clinically defined breast cancer subgroups

CDK4/6 inhibition in luminal breast cancer

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Triple-negative breast cancer molecular subtyping and treatment progress

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

GRHL2-controlled gene expression networks in luminal breast cancer

Chemosensitivity testing in gynecologic malignancies and breast cancer : 30 tables

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells

Related objects

Reset password